NCT06969144

Brief Summary

Subtotal cholecystectomy (STC) is a valuable technique when severe inflammation, fibrosis, or anatomical variations obscure the critical view of safety essential for identifying the cystic duct and artery. It helps reduce the risk of bile duct injuries and other complications that arise during a total cholecystectomy (TC) when these structures are not visible. This study evaluates the safety and outcomes of subtotal cholecystectomy in chronic cholecystitis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,149

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Dec 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 23, 2024

Completed
20 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 12, 2025

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 13, 2025

Completed
14 days until next milestone

First Submitted

Initial submission to the registry

January 27, 2025

Completed
4 months until next milestone

First Posted

Study publicly available on registry

May 13, 2025

Completed
Last Updated

May 13, 2025

Status Verified

January 1, 2025

Enrollment Period

20 days

First QC Date

January 27, 2025

Last Update Submit

May 6, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • postoperative outcomes of subtotal cholecystectomy (STC) and total cholecystectomy (TC)

    The primary outcome was to assess the postoperative outcomes of subtotal cholecystectomy (STC) and total cholecystectomy (TC) groups.

    upto 22 months

Interventions

The indications for elective cholecystectomy were symptomatic cholelithiasis, a GB polyp more than ten millimeters, a history of cholecystitis, biliary pancreatitis, or choledocholithiasis. Patients with cholecystitis and severe or moderately severe pancreatitis were operated on after six weeks of the event. Other patients received surgery at the earliest available date. All patients with choledocholithiasis underwent endoscopic retrograde cholangiopancreatography (ERCP) and stone clearance before cholecystectomy. Patients who underwent laparoscopic cholecystectomy were evaluated by surgical and anesthesia teams in outpatient clinics and co-morbid conditions were optimized. Preoperative antibiotic prophylaxis was given to all the patients before induction of anesthesia.

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

patients undergoing laparoscopic cholecystectomy

You may qualify if:

  • Clinical diagnosis of cholelithiasis planned for laparoscopic cholecystectomy
  • Clinical diagnosis of gallbladder polyp planned for laparoscopic cholecystectomy

You may not qualify if:

  • Gall bladder malignancy
  • Cholelithiasis and gallbladder polyp cases managed non-operatively
  • additional procedures along with cholecystectomy like bile duct exploration, bile duct excision for choledochal cyst.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tribhuvan University Teaching Hospital, Kathmandu, Nepal

Kathmandu, 44600, Nepal

Location

MeSH Terms

Conditions

Gallstones

Interventions

Cholecystectomy

Condition Hierarchy (Ancestors)

CholelithiasisBiliary Tract DiseasesDigestive System DiseasesCholecystolithiasisGallbladder DiseasesCalculiPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Biliary Tract Surgical ProceduresDigestive System Surgical ProceduresSurgical Procedures, Operative

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

January 27, 2025

First Posted

May 13, 2025

Study Start

December 23, 2024

Primary Completion

January 12, 2025

Study Completion

January 13, 2025

Last Updated

May 13, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will share

apart from identifiers, relevant clinical data.

Shared Documents
STUDY PROTOCOL, ICF
Time Frame
as supplementary file
Access Criteria
as supplementary file

Locations